Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum

References

• Gonococcal infections among neonates-STI treatment guidelines. https://www.cdc.gov/std/treatment-guidelines/gonorrhea-neonates.htm ( Accessed 21 Sep 2022).
   Google Scholar
• Hu V, Caswell R, Last A, Burton M, Mabey D. Trachoma and inclusion conjunctivitis. Hunter's Trop. Med. Emerg. Infect. Dis. Elsevier 421–428 (2020).
   Google Scholar
• Dolange V, Churchward CP, Christodoulides M, Snyder LAS. The growing threat of gonococcal blindness. Antibiot. Basel. Switz. 7(3), 59 (2018).
   PubMed Web of Science ®Google Scholar
• Ochoa KJC, Mendez MD. Ophthalmia Neonatorum. In: StatPearls. StatPearls Publishing, Treasure Island (FL) (2022).
   Google Scholar
• McAnena L, Knowles SJ, Curry A, Cassidy L. Prevalence of gonococcal conjunctivitis in adults and neonates. Eye (Lond) 29(7), 875–880 (2015).
   PubMed Web of Science ®Google Scholar
• Kapoor VS, Evans JR, Vedula SS. Interventions for preventing ophthalmia neonatorum. Cochrane Database Syst. Rev. 9(9), CD001862 (2020).
   PubMedGoogle Scholar
• Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int. J. STD AIDS 31(1), 4–15 (2020).
   PubMed Web of Science ®Google Scholar
• WHO guidelines for the treatment of Neisseria gonorrhoeae. https://www.who.int/publications-detail-redirect/9789241549691 ( Accessed 5 Aug 2022).
   Google Scholar
• Soni S, Horner P, Rayment M et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int. J. STD AIDS 30(10), 938–950 (2019).
   PubMed Web of Science ®Google Scholar
• Liu Y, Feinen B, Russell M. New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host. Front. Microbiol. 2, 52 (2011).
   PubMed Web of Science ®Google Scholar
• Donham BP, Gibler WB. Images in emergency medicine. Gonococcal conjunctivitis. Ann. Emerg. Med. 52(1), 11–16 (2008).
   PubMedGoogle Scholar
• Kawashima M, Kawakita T, Den S, Tomita M, Shimazaki J. Surgical management of corneal perforation secondary to gonococcal keratoconjunctivitis. Eye (Lond) 23, 339–344 (2009).
   PubMed Web of Science ®Google Scholar
• Ukachukwu FU, Rafiq A, Snyder LAS. Challenges in treating ophthalmia neonatorum. Expert Rev. Ophthalmol. 16(1), 19–32 (2021).
   Web of Science ®Google Scholar
• American Academy of Pediatrics. Prevention of neonatal ophthalmia. In: Red Book: 2012 Report of the Committee on Infectious Diseases (29th ed.). Pickering LK, Baker CJ, Kimberlin DW, Long SS ( Eds). Elk Grove Village, American Academy of Pediatrics, 880–882 (2012).
   Google Scholar
• Suggs KS, Tito E, Muthukumarasamy N, Schauer M. Meningitis secondary to disseminated gonococcal infection. BMJ Case Rep. 14(9), e244895 (2021).
   PubMedGoogle Scholar
• Lohani S, Nazir S, Tachamo N, Patel NJ. Disseminated gonococcal infection: an unusual presentation. Community Hosp. Intern. Med. Perspect. 6(3), 31841 (2016).
   PubMedGoogle Scholar
• Rowley J, Vander Hoorn S, Korenromp E et al. Chlamydia, gonorrhea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 97(8), 548–562 (2019).
   PubMed Web of Science ®Google Scholar
• https://www.who.int/news-room/fact-sheets/detail/multi-drug-resistant-gonorrhea
   Google Scholar
• Vaezzadeh K, Sepidarkish M, Mollalo A et al. Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis. Clin. Microbiol. Infect. 29(1), 22–31 (2023).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections (2021). http://www.who.int/publications/i/item/9789240027077 ( Accessed on December 22, 2022).
   Google Scholar
• Tacconelli E, Carrara E, Savoldi A et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 18(3), 318–327 (2018).
   PubMed Web of Science ®Google Scholar
• Darling EK, McDonald H. A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. J. Midwifery Womens Health 55(4), 319–327 (2010).
   PubMed Web of Science ®Google Scholar
• Jin J. Prevention of gonococcal eye infection in newborns. JAMA 321(4), 414 (2019).
   PubMedGoogle Scholar
• Matejcek A, Goldman RD. Treatment and prevention of ophthalmia neonatorum. Can. Fam. Physician 59(11), 1187–1190 (2013).
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK et al. Ocular prophylaxis for gonococcal ophthalmia neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA 321(4), 394–398 (2019).
   PubMed Web of Science ®Google Scholar
• Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G. Neonatal conjunctivitis – a review. Malays Fam Physician 3(2), 77–81 (2008).
   PubMedGoogle Scholar
• Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin. Infect. Dis. 53(Suppl. 3), S99–S102 (2011).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines (2015). http://www.cdc.gov/std/tg2015 ( cited 2016 Dec 22).
   Google Scholar
• Day M, Pitt R, Mody N et al. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Euro Surveill. 27(46), 2200803 (2022).
   PubMedGoogle Scholar
• Berçot B, Caméléna F, Mérimèche M et al. Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022. Euro Surveill. 27(50), 2200899 (2022).
   PubMedGoogle Scholar
• Bharara T, Bhalla P, Rawat D, Garg VK, Sardana K, Chakravarti A. Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone. Indian J. Med. Microbiol. 33(1), 39–42 (2015).
   PubMed Web of Science ®Google Scholar
• Ross JDC, Brittain C, Cole M et al. Gentamicin compared with ceftriaxone for the treatment of gonorrhea (G-ToG): a randomised non-inferiority trial. Lancet 393(10190), 2511–2520 (2019).
   PubMed Web of Science ®Google Scholar
• Lin EY, Adamson PC, Klausner JD. Epidemiology, treatments, and vaccine development for antimicrobial-resistant Neisseria gonorrhoeae: current strategies and future directions. Drugs 81(10), 1153–1169 (2021).
   PubMed Web of Science ®Google Scholar
• de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLOS Med. 13(11), e100218413 (2016).
   Web of Science ®Google Scholar
• O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance. (2016). https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf ( Accessed on 21 August 2023).
   Google Scholar
• Unemo M, Nicholas RA. Emergence of multi drug resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7(12), 1401–1422 (2012).
   PubMed Web of Science ®Google Scholar
• WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed ( Accessed 21 Sep 2022).
   Google Scholar
• Młynarczyk-Bonikowska B, Majewska A, Malejczyk M, Młynarczyk G, Majewski S. Multi-resistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med. Microbiol. Immunol. 209(2), 95–108 (2020).
   PubMed Web of Science ®Google Scholar
• Price R. O'Neill report on antimicrobial resistance: funding for antimicrobial specialists should be improved. Eur. J. Hosp. Pharm. 23(4), 245–247 (2016).
   PubMedGoogle Scholar
• Eyre DW, Sanderson ND, Lord E et al. gonorrhea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill 23(27), 1800323 (2018).
   PubMedGoogle Scholar
• Liu Y, Ding S, Shen J, Zhu K. Nonribosomal antibacterial peptides that target multidrug-resistant bacteria. Nat. Prod. Rep. 36(4), 573–592 (2019).
   PubMed Web of Science ®Google Scholar
• Berenger BM, Demczuk W, Gratrix J, Pabbaraju K, Smyczek P, Martin I. Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018. Emerg. Infect. Dis. 25(9), 1660–1667 (2019).
   PubMed Web of Science ®Google Scholar
• Wi T, Lahra MM, Ndowa F et al. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 14(7), e1002344 (2017).
   PubMed Web of Science ®Google Scholar
• Al-Maslamani M, Elmagboul EBI, Puthiyottil A et al. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017–2020. PLOS ONE 17(3), e0264737 (2022).
   PubMed Web of Science ®Google Scholar
• Chung GT, Yoo JS, Oh HB et al. The complete genome sequence of Neisseria gonorrhoeae NCCP11945. J. Bacteriol. 190, 6035–6036 (2008).
   PubMed Web of Science ®Google Scholar
• Chen Y, Gong Y, Yang T et al. Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysis. BMC Infect Dis. 16, 108 (2016).
   PubMed Web of Science ®Google Scholar
• Agarwal J, Radera S, Suvirya S, Awasthi M. Antibiotic resistance in Neisseria gonorrhoeae isolated from a tertiary care center in North India. Indian J. Sex Transm. Dis. AIDS 40(2), 182–184 (2019).
   PubMed Web of Science ®Google Scholar
• Gjini E, Brito PH. Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment. PLOS Comput. Biol. 12(4), e1004857 (2016).
   PubMed Web of Science ®Google Scholar
• Stalteri Mastrangelo R, Santesso N, Bognanni A et al. Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey. BMJ Open 11(7), e046097 (2021).
   PubMed Web of Science ®Google Scholar
• Lamar RV. Chemo-immunological studies on localized infections: second paper: Lysis of the pneumococcus and hemolysis by certain fatty acids and their alkali soaps. J. Exp. Med. 13(3), 380–386 (1911).
   PubMedGoogle Scholar
• Jefferson A, Smith A, Fasinu PS, Thompson DK. Sexually Transmitted Neisseria gonorrhoeae Infections-Update on Drug Treatment and Vaccine Development. Medicines (Basel) 8(2), 11 (2021).
   PubMedGoogle Scholar
• Anonye BO, Nweke V, Furner-Pardoe J et al. The safety profile of Bald's eyesalve for the treatment of bacterial infections. Sci. Rep. 10, 17513 (2020).
   PubMed Web of Science ®Google Scholar
• Harrison F, Roberts AE, Gabrilska R, Rumbaugh KP, Lee C, Diggle SP. A 1,000-year-old antimicrobial remedy with anti staphylococcal activity. mBio 6(4), e01129 (2015).
   PubMed Web of Science ®Google Scholar
• Yoon BK, Jackman JA, Valle-González ER, Cho NJ. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. Int. J. Mol. Sci. 19(4), 1114 (2018).
   PubMed Web of Science ®Google Scholar
• Bergsson G, Steingrímsson O, Thormar H. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrob. Agents Chemother. 43(11), 2790–2792 (1999).
   PubMed Web of Science ®Google Scholar
• Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob. Agents Chemother. 45(11), 3209–3212 (2001).
   PubMed Web of Science ®Google Scholar
• Churchward CP, Al-Kinani AA, Abdelkader H et al. Monocaprin eye drop formulation to combat antibiotic resistant gonococcal blindness. Sci. Rep. 10, 12010 (2020).
   PubMed Web of Science ®Google Scholar
• Churchward CP, Alany RG, Snyder LAS. Alternative antimicrobials: the properties of fatty acids and monoglycerides. Crit. Rev. Microbiol. 44(5), 561–570 (2018).
   PubMed Web of Science ®Google Scholar
• Churchward CP, Calder A, Snyder LAS. Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance. PLOS ONE 13(4), e0195453 (2018).
   PubMed Web of Science ®Google Scholar
• Russell MW, Jerse AE, Gray-Owen SD. Progress toward a gonococcal vaccine: the way forward. Front Immunol. 10, 2417 (2019).
   PubMed Web of Science ®Google Scholar
• Giri S, Markandeywar TS, Irfan Z, Manna S. Gellan gum and sodium alginate in-situ gel of monocaprin for effective corneal permeation. Food Hydrocolloids for Health 4, 100156 (2023).
   Google Scholar
• Butt U, ElShaer A, Snyder LAS, Al-Kinani AA, Le Gresley A, Alany RG. Fatty acid based microemulsions to combat ophthalmia neonatorum caused by Neisseria gonorrhoeae and Staphylococcus aureus. Nanomaterials (Basel) 8(1), 51 (2018).
   PubMedGoogle Scholar
• Seyfi R, Kahaki FA, Ebrahimi T et al. Antimicrobial peptides (AMPs): roles, functions and mechanism of action. Int. J. Pept. Res. Ther. 26, 1451–1463 (2020).
   Web of Science ®Google Scholar
• Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 6, 194 (2016).
   PubMed Web of Science ®Google Scholar
• Xuan J, Feng W, Wang J et al. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist. Updat. 68, 100954 (2023).
   PubMed Web of Science ®Google Scholar
• Askari P, Yousefi M, Foadoddini M et al. Antimicrobial peptides as a promising therapeutic strategy for Neisseria infections. Curr. Microbiol. 79(4), 102 (2022).
   PubMed Web of Science ®Google Scholar
• Kiattiburut W, Zhi R, Lee SG et al. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae. Hum. Reprod. 33(12), 2175–2183 (2018).
   PubMed Web of Science ®Google Scholar
• Cox DL, Sun Y, Liu H, Lehrer RI, Shafer WM. Susceptibility of Treponema pallidum to host-derived antimicrobial peptides. Peptides 24(11), 1741–1746 (2003).
   PubMed Web of Science ®Google Scholar
• Moncla B, Mietzner T, Hillier S. In vitro activity of cationic peptides against Neisseria gonorrhoeae and vaginal Lactobacillus species: the effect of divalent cations. Adv. Biosci. Biotechnol. 3(3), 249–255 (2012).
   Google Scholar
• Shafer W, Qu X-D, Waring A, Lehrer R. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl Acad. Sci. USA 95(4), 1829–1833 (1998).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Furunaka H, Miyata T et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem. 263(32), 16709–16713 (1988).
   PubMed Web of Science ®Google Scholar
• Edwards IA, Elliott AG, Kavanagh AM, Blaskovich MA, Cooper MA. Structure-activity and- toxicity relationships of the antimicrobial peptide tachyplesin-1. ACS Infect Dis. 3(12), 917–926 (2017).
   PubMed Web of Science ®Google Scholar
• Qu X-D, Harwig S, Shafer WM, Lehrer RI. Protegrin structure and activity against Neisseria gonorrhoeae. Infect. Immun. 65(2), 636–639 (1997).
   PubMed Web of Science ®Google Scholar
• Steinberg DA, Hurst MA, Fujii CA et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41(8), 1738–1742 (1997).
   PubMed Web of Science ®Google Scholar
• Lee SB, Li B, Jin S, Daniell H. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol. J. 9(1), 100–115 (2011).
   PubMed Web of Science ®Google Scholar
• Arpornsuwan T, Buasakul B, Jaresitthikunchai J, Roytrakul S. Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae. Peptides 53, 315–320 (2014).
   PubMed Web of Science ®Google Scholar
• Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochimica Biophys Acta (BBA)-Biomembr. 1462(1–2), 11–28 (1999).
   PubMed Web of Science ®Google Scholar
• Sikora AE, Mills RH, Weber JV et al. Peptide inhibitors targeting the Neisseria gonorrhoeae pivotal anaerobic respiration factor AniA. Antimicrob. Agents Chemother. 61(8), e186–e217 (2017).
   Web of Science ®Google Scholar
• Mellies J, Jose J, Meyer T. The Neisseria gonorrhoeae gene aniA encodes an inducible nitrite reductase. Mol. Gen. Genet MGG. 256(5), 525–532 (1997).
   Google Scholar
• Yenugu S, Narmadha G. The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics. J. Pept. Sci. 16(7), 337–341 (2010).
   PubMed Web of Science ®Google Scholar
• Yenugu S, Hamil KG, French FS, Hall SH. Antimicrobial actions of the human epididymis 2 (HE2) protein isoforms, HE2alpha, HE2beta1 and HE2beta2. Reprod. Biol. Endocrinol. 2(1), 61 (2004).
   PubMedGoogle Scholar
• Liao M, Ruddock P, Rizvi A, Hall S, French F, Dillon J. Cationic peptide of the male reproductive tract, HE2a, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. J. Antimicrob. Chemother. 56(5), 957–961 (2005).
   PubMed Web of Science ®Google Scholar
• Mota-Meira M, Lapointe G, Lacroix C, Lavoie MC. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44(1), 24–29 (2000).
   PubMed Web of Science ®Google Scholar
• Mota-Meira M, Lacroix C, LaPointe G, Lavoie MC. Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett. 410(2–3), 275–279 (1997).
   PubMed Web of Science ®Google Scholar
• Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Delivery Rev. 65, 1803–1815 (2013).
   PubMed Web of Science ®Google Scholar
• Baptista PV, McCusker MP, Carvalho A et al. Nano-strategies to fight multidrug resistant bacteria-“A Battle of the Titans”. Front Microbiol. 9, 1441 (2018).
   PubMed Web of Science ®Google Scholar
• Lucío MI, Kyriazi ME, Hamilton J et al. Bactericidal Effect of 5-Mercapto-2-nitrobenzoic Acid-Coated Silver Nanoclusters against Multidrug-Resistant Neisseria gonorrhoeae. ACS Appl. Mater Interfaces 12(25), 27994–28003 (2020).
   PubMed Web of Science ®Google Scholar
• Yang TY, Tseng SP, Ho HC et al. In Vitro evaluation of tellurium-based AS101 compound against Neisseria gonorrhoeae infectivity. Microbiol. Spectr. 11(2), e0149622 (2023).
   PubMed Web of Science ®Google Scholar
• Alqahtani F, Aleanizy F, El Tahir E et al. Antibacterial activity of chitosan nanoparticles against pathogenic N. gonorrhea. Int. J. Nanomedicine 15, 7877–7887 (2020).
   PubMed Web of Science ®Google Scholar
• Li LH, Yen MY, Ho CC et al. Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae. PLOS ONE 8(5), e64794 (2013).
   PubMed Web of Science ®Google Scholar
• Ateia EE, Arman MM, Mohamed AT. A facile novel synthesis of AgCuO2 delafossite nanoparticles and evaluation of their antimicrobial activity. Sci. Rep. 13(1), 3141 (2023).
   PubMed Web of Science ®Google Scholar
• Cern A, Bavli Y, Hod A et al. Therapeutic potential of injectable nano-mupirocin liposomes for infections involving multidrug-resistant bacteria. Pharmaceutics 13(12), 2186 (2021).
   PubMed Web of Science ®Google Scholar
• Jackman JA, Yoon BK, Li D, Cho NJ. Nanotechnology formulations for antibacterial free fatty acids and monoglycerides. Molecules 21(3), 305 (2016).
   PubMed Web of Science ®Google Scholar
• Thormar H, Bergsson G, Gunnarsson E et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex Transm. Infect. 75, 181–185 (1999).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Su X. Antibacterial activity of 18beta-glycyrrhetinic acid against Neisseria gonorrhoeae in vitro. Biochem. Biophys Rep. 33, 101427 (2023).
   PubMedGoogle Scholar
• Park S, Russo R, Westfall L et al. A novel oral GyrB/ParE dual binding inhibitor effective against multidrug-resistant Neisseria gonorrhoeae and other high-threat pathogens. Antimicrob. Agents Chemother. 66, e0041422 (2022).
   PubMed Web of Science ®Google Scholar
• Piekarowicz A, Majchrzak M, Kłyz A, Adamczyk-Popławska M. Analysis of the filamentous bacteriophage genomes integrated into Neisseria gonorrhoeae FA1090 chromosome. Polish J. Microbiol. 55(4), 251–260 (2006).
   PubMed Web of Science ®Google Scholar
• Piekarowicz A, Kłyz A, Majchrzak M, Adamczyk-Popławska M, Maugel TK, Stein DC. Characterization of the dsDNA prophage sequences in the genome of Neisseria gonorrhoeae and visualization of productive bacteriophage. BMC Microbiol. 7, 66 (2007).
   PubMed Web of Science ®Google Scholar
• Piekarowicz A, Kłyż A, Majchrzak M et al. Neisseria gonorrhoeae filamentous phage NgoΦ6 is capable of infecting a variety of Gram-negative bacteria. J. Virol. 88(2), 1002–1010 (2014).
   PubMed Web of Science ®Google Scholar
• Adamczyk-Popławska M, Golec P, Piekarowicz A, Kwiatek A. The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea. Crit. Rev. Microbiol. 28, 1–16 (2023).
   Google Scholar
• Cater K, Międzybrodzki R, Morozova V et al. Potential for phages in the treatment of bacterial sexually transmitted infections. Antibiotics 10(9), 1030 (2021).
   Google Scholar
• Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat. Rev. Microbiol. 16(4), 226–240 (2018).
   PubMed Web of Science ®Google Scholar
• Griffin PJ, Rieder SV. A study on the growth requirements of Neisseria gonorrhoeae and its clinical application. Yale J. Biol. Med. 29(6), 613–621 (1957).
   PubMedGoogle Scholar
• Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 85(6), 1629–1642 (2010).
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol. Spectr. 4(2), (2016).
   PubMed Web of Science ®Google Scholar
• Whiley DM, Jennison A, Pearson J, Lahra MM. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. Lancet Infect Dis. 18(7), 717–718 (2018).
   PubMed Web of Science ®Google Scholar
• Williams MR, Stedtfeld RD, Waseem H et al. Implications of direct amplification for measuring antimicrobial resistance using point-of-care devices. Anal. Methods Adv. Methods Appl. 9(8), 1229–1241 (2017).
   Google Scholar
• Unemo M, Lahra MM, Escher M et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe 2(11), e627–e636 (2021).
   PubMedGoogle Scholar
• Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat. Rev. Microbiol. 16(4), 226–240 (2018).
   PubMed Web of Science ®Google Scholar
• Aslam B, Khurshid M, Arshad MI et al. Antibiotic resistance: one health one world outlook. Front Cell Infect Microbiol. 11, 771510 (2021).
   PubMed Web of Science ®Google Scholar
• Chanda W, Joseph TP, Guo XF et al. Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens. J. Zhejiang Univ. Sci. B 19(4), 253–262 (2018).
   PubMed Web of Science ®Google Scholar
• Morselli S, Valente S, Foschi C, Marangoni A, Pasquinelli G. Effect of different fatty acids on Neisseria gonorrhoeae viability. New Microbiol. 44(3), 164–172 (2021).
   PubMed Web of Science ®Google Scholar
• Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLOS One 7(7), e40350 (2012).
   PubMed Web of Science ®Google Scholar
• Drake DR, Brogden KA, Dawson DV, Wertz PW. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid Res. 49(1), 4–11 (2008).
   PubMed Web of Science ®Google Scholar
• Thormar H, Hilmarsson H, Bergsson G. Stable concentrated emulsions of the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the food-borne bacteria Campylobacter jejuni, Salmonella spp, and Escherichia coli. Appl. Environ. Microbiol. 72(1), 522–526 (2006).
   PubMed Web of Science ®Google Scholar
• Su B, Wang Y, Jian S et al. In vitro and in vivo antiviral activity of monolaurin against Seneca Valley virus. Front Vet. Sci. 10, 980187 (2023).
   PubMed Web of Science ®Google Scholar